NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.17 +0.79 (+1.01%) GOLD FUTURES
2,318.80 -5.40 (-0.23%) DOW
39,057.72 +173.46 (+0.45%) Bitcoin GBP
49,753.46 -767.11 (-1.52%)
CLRB May 2024 5.000 call
| Previous close | 0.1500 |
| Open | 0.1500 |
| Bid | 0.0500 |
| Ask | 0.1000 |
| Strike | 5.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0900 - 0.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.26k |
GlobeNewswireCellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
FLORHAM PARK, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that Jarrod Longcor, chief operating officer of Cellectar, will present an overview of the company in a fireside chat at the upcoming Guggenheim Healthcare Talks Radiopharmaceuticals Day being held on May 13, 2024 in New York City. Details
- GlobeNewswire
Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024
FLORHAM PARK, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that the company will report its financial results for the three months ended March 31, 2024, on Tuesday, May 14, 2024. Management will also host a conference call with investors to discuss financial results and provide an overview at 8:30
Simply Wall St.Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?
We feel now is a pretty good time to analyse Cellectar Biosciences, Inc.'s ( NASDAQ:CLRB ) business as it appears the...
